OpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Control
“OpGen was honored to work with the CDC and our partners to help address this urgent global need,” said
“Dr. Villegas and the UEB team guided the customization of the AMS software for the needs of low- and middle-income countries. They also worked with
ILÚM Health Solutions is a provider of technology and services to support infectious disease management, clinical decision-support and precision antibiotic therapy. ILÚM is part of
This press release includes statements relating to OpGen’s expectations regarding the use of the Insight products in the future in other economically-challenged countries. These statements and other statements regarding OpGen’s future plans constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond OpGen’s control, and which may cause results to differ materially from expectations. Factors that could cause results to differ materially from those described include, but are not limited to, OpGen’s ability to successfully implement the awarded contract. For a discussion of the most significant risks and uncertainties associated with
Source: OpGen, Inc.